Virtu Financial, Inc. (VIRT)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,630	3,067	1,833	2,037	3,239	3,094
Market Cap Growth	94.21%	67.31%	-10.01%	-37.11%	4.68%	64.34%
Last Close Price	43.37	35.23	19.25	18.40	25.04	21.11
PE Ratio	9.86	11.78	13.69	7.98	6.99	4.90
PS Ratio	1.42	1.38	1.09	1.01	1.25	1.05
PB Ratio	2.61	2.06	1.30	1.23	1.74	1.67
P/FCF Ratio	11.74	5.23	4.04	3.00	2.82	3.00
P/OCF Ratio	11.40	5.12	3.73	2.88	2.76	2.92
Debt / Equity Ratio	4.55	3.94	3.80	2.26	1.94	1.86
Debt / FCF Ratio	13.17	10.00	11.77	5.49	3.15	3.34
Asset Turnover	0.16	0.15	0.13	0.19	0.26	0.30
Quick Ratio	1.09	1.11	1.12	1.23	1.23	1.23
Current Ratio	1.10	1.12	1.12	1.23	1.23	1.23
Return on Equity (ROE)	50.80%	36.96%	17.27%	26.65%	44.49%	72.69%
Return on Assets (ROA)	4.68%	3.58%	2.11%	4.48%	8.16%	11.45%
Earnings Yield	5.72%	9.01%	7.75%	13.01%	14.72%	20.98%
FCF Yield	8.52%	19.13%	24.77%	33.36%	35.42%	33.36%
Dividend Yield	2.21%	2.73%	4.99%	5.22%	3.83%	4.55%
Payout Ratio	21.84%	32.21%	66.77%	38.96%	24.19%	18.56%
Buyback Yield / Dilution	4.26%	6.65%	9.91%	11.82%	3.19%	-7.39%
Total Shareholder Return	6.47%	9.37%	14.90%	17.04%	7.03%	-2.84%

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.

SEC Filings: 10-K · 10-Q